Ex Parte Cheng - Page 13

               Appeal 2006-2453                                                                             
               Application 10/302,391                                                                       
                      re Fritch, 972 F.2d 1260, 1266, 23 USPQ2d 1780, 1783-74 (Fed. Cir.                    
                      1992).                                                                                
               10) Once the PTO has made an initial determination that specified claims                     
                      are not patentable (the prima facie case concept, see In re Oetiker, 977              
                      F.2d 1443, 1448, 24 USPQ2d 1443, 1447 (Fed. Cir. 1992) (Plager, J.                    
                      concurring)), the burden of production falls upon the applicant to                    
                      establish entitlement to a patent.  See In re Spada, 911 F.2d 705, 708,               
                      15 USPQ2d 1655, 1658 (Fed. Cir. 1990).                                                
               11) The Board has broad discretion as to the weight to give to declarations                  
                      offered in the course of prosecution.  See Velander v. Garner, 348                    
                      F.3d 1359, 1371, 68 USPQ2d 1769, 1778 (Fed. Cir. 2003)                                
               12) “Although there is ‘no reason why opinion evidence relating to a fact                    
                      issue should not be considered by an examiner,’ In re Alton, 76 F.3d                  
                      1168, 1175 n. 10 (Fed.Cir.1996), the Board is entitled to weigh the                   
                      declarations and conclude that the lack of factual corroboration                      
                      warrants discounting the opinions expressed in the declarations.”  In                 
                      re American Academy of Science Tech Center, 367 F.3d 1359, 1368,                      
                      70 USPQ2d 1827, 1833 (Fed. Cir. 2004).                                                

                                   ANALYSIS AND CONCLUSIONS                                                 
                                                 Simonetti                                                  
                      Claims 1-5:                                                                           
                      Appellants argue, inter alia, that Simonetti does not disclose applying               
               a UV curable adhesive across the width of the membrane sheet.  Br. 7.                        
               Rather, Simonetti’s application of the adhesive is limited to leak paths, i.e.,              
               along the edges of the membrane sheet and in isolated existing cracks near                   


                                                    13                                                      

Page:  Previous  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  Next

Last modified: September 9, 2013